𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trial in duchenne dystrophy. I. The design of the protocol

✍ Scribed by Dr. Michael H. Brooke; Dr. Robert C. Griggs; Dr. Jerry R. Mendell; Dr. Gerald M. Fenichel; Jack B. Shumate; Dr. Richard J. Pellegrino


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
897 KB
Volume
4
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Reliable surrogate outcome measures in m
✍ Jill E. Mayhew; Julaine M. Florence; Thomas P. Mayhew; Erik K. Henricson; Robert πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 176 KB

## Abstract We studied the reliability of a series of endpoints in an evaluation of subjects with Duchenne muscular dystrophy (DMD). The endpoints included quantitative muscle tests (QMTs), timed function tests, forced vital capacity (FVC), and manual muscle tests (MMT). Thirty‐one ambulatory subje

A trial of flunarizine in the treatment
✍ Dr. David J. Dick; David Gardner-medwin; Peter G. Gates; Mary Gibson; Judy M. Si πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 491 KB

Twenty-seven boys with Duchenne muscular dystrophy (DMD) entered a double-blind controlled trial of treatment with the calcium antagonist flunarizine. They were matched for age and disability. At monthly intervals, muscle power, functional ability, locomotor score, contractures, and forced vital cap

Duchenne-like muscular dystrophy in the
✍ Farag, Talaat I. ;Teebi, Ahmad S. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 2 views